Reverie Labs
ClosedEngineering next-generation, brain-penetrant cancer therapies.
Cambridge, United States · Founded 2017 · $32.0M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 11–50
- Founded
- 2017
- Website
- reverielabs.com
- Total Funding
- $32.0M
- Last Round
- $7.0M Seed
- Rounds
- 2
About
Reverie Labs is engineering next-generation, brain-penetrant cancer therapies.
Summary
Reverie Labs is a Biotech company based in Cambridge, United States, founded in 2017. It has raised $32.0M in total across 2 rounds. Investors include General Catalyst, Ridgeback Capital and BoxGroup.
Tech & App Stack
20 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Unknown
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Global contract research organization providing comprehensive drug development and laboratory ser...
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.